www.fdanews.com/articles/71449-bentley-to-present-results-of-initial-phase-ii-intranasal-insulin-study
Bentley to Present Results of Initial Phase II Intranasal Insulin Study
April 22, 2005
Bentley Pharmaceuticals has recently completed a data analysis of its Phase II clinical trial in Ireland of its proprietary intranasal insulin.
Bentley will report the results in an abstract, titled "Intranasal Insulin Administration in Type I Diabetic Patients Utilizing CPE-215 Technology" at the American Diabetes Association 65th Scientific Sessions, June 10-14.
Bentley previously reported successful completion of the study at the end of 2004. Previous studies of the intranasal insulin development program were published in Diabetes Technology and Therapeutics.